- Home
- BLTE vs CNMD Comparison
BLTE vs CNMD Comparison
Compare BLTE & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLTE
- CNMD
- Stock Information
- Founded
- BLTE 2018
- CNMD 1970
- Country
- BLTE United States
- CNMD United States
- Employees
- BLTE N/A
- CNMD N/A
- Industry
- BLTE Biotechnology: Pharmaceutical Preparations
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BLTE Health Care
- CNMD Health Care
- Exchange
- BLTE Nasdaq
- CNMD Nasdaq
- Market Cap
- BLTE 2.1B
- CNMD 1.7B
- IPO Year
- BLTE 2022
- CNMD 1987
- Fundamental
- Price
- BLTE $65.74
- CNMD $55.00
- Analyst Decision
- BLTE Strong Buy
- CNMD Hold
- Analyst Count
- BLTE 4
- CNMD 5
- Target Price
- BLTE $96.67
- CNMD $59.80
- AVG Volume (30 Days)
- BLTE 39.8K
- CNMD 365.1K
- Earning Date
- BLTE 08-11-2025
- CNMD 10-29-2025
- Dividend Yield
- BLTE N/A
- CNMD 1.46%
- EPS Growth
- BLTE N/A
- CNMD 12.82
- EPS
- BLTE N/A
- CNMD 3.54
- Revenue
- BLTE N/A
- CNMD $1,326,244,000.00
- Revenue This Year
- BLTE N/A
- CNMD $6.73
- Revenue Next Year
- BLTE N/A
- CNMD $5.45
- P/E Ratio
- BLTE N/A
- CNMD $15.45
- Revenue Growth
- BLTE N/A
- CNMD 3.94
- 52 Week Low
- BLTE $43.70
- CNMD $46.00
- 52 Week High
- BLTE $86.53
- CNMD $78.19
- Technical
- Relative Strength Index (RSI)
- BLTE 52.03
- CNMD 55.60
- Support Level
- BLTE $62.18
- CNMD $52.02
- Resistance Level
- BLTE $66.15
- CNMD $55.15
- Average True Range (ATR)
- BLTE 2.66
- CNMD 1.61
- MACD
- BLTE -0.16
- CNMD -0.02
- Stochastic Oscillator
- BLTE 72.80
- CNMD 66.88
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.